Clinical Trial Update: Clamp Study Comparing Inhalation of Technosphere®/Insulin in Smokers and Non-Smokers With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial update comparing inhaled Technosphere insulin in smokers and non-smokers with Type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Afrezza (Technosphere insulin)

Snippet

Sponsor: Mannkind Corporation | Conditions: Diabetes Type 2 | Phase 2 | Status: COMPLETED